Where Do Peptides Come From? (And Could You Make Your Own?)

Peptides aren't harvested — they're built, amino acid by amino acid, on automated machines. The synthesis is the easy part; the other 90% is why 'make your own' fails.

Every vial of peptide in the world — the approved drug in a pharmacy pen, the clinic’s compounded supply, the gray-market powder — started as chemistry, not biology. Nobody milks a gland for BPC-157. This page explains how peptides are actually manufactured, where the machines and factories are, and why the obvious follow-up question — couldn’t someone just make their own? — has a short economic answer and a shorter legal one.

Built, not harvested: solid-phase synthesis

The standard method is solid-phase peptide synthesis (SPPS), the technique that won its inventor, Bruce Merrifield, a Nobel Prize. In outline:

1. The first amino acid is anchored to a tiny resin bead.
2. The chain is built one amino acid at a time — each cycle adds the next building block, washes away the excess, and unblocks the growing end for the next addition. A 15-amino-acid peptide like BPC-157 takes 15 cycles; a longer chain takes proportionally more, and errors compound with length.
3. The finished chain is cut loose from the resin (cleavage), leaving a crude mixture: the target peptide, plus truncated chains, wrong-sequence cousins, and chemical leftovers from every cycle.

The synthesis itself is thoroughly automated. Peptide synthesizers are ordinary commercial laboratory equipment — instruments in the class of CEM’s Liberty Blue line, Biotage’s synthesizers, and AAPPTEC’s systems sit in university labs, biotech firms, and contract manufacturers worldwide, at prices running from the tens of thousands of dollars into the $150,000-plus range for high-throughput models. The machine is not the moat. What comes after it is.

Copies of the body’s own fragments

Most peptides in the news are synthetic copies of — or fragments of — molecules the body makes:

• BPC-157 is a 15-amino-acid sequence modeled on a protective protein found in human gastric juice. The natural protein was the template; every vial of BPC-157 in existence was built by synthesis.
• TB-500 is a fragment of thymosin beta-4, a 43-amino-acid protein found throughout the body. The fragment is synthesized; it is not extracted from anyone’s thymus.
• GHK-Cu is a three-amino-acid peptide (glycine–histidine–lysine) manufactured synthetically and bound to a copper ion.

“Modeled on a natural molecule” describes the blueprint. The product is industrial.

The pharmaceutical exception: grown, then finished

The big GLP-1 drugs are made at a different scale and partly by a different route. Manufacturers including Novo Nordisk produce key parts of semaglutide using engineered yeast fermentation — living cells grow a precursor — followed by chemical finishing steps that attach the modifications making the molecule long-acting. It is biotechnology and chemistry in sequence, run in dedicated plants, under pharmaceutical quality systems, at a scale no bench synthesizer approaches. Either way — full synthesis or fermentation-plus-finishing — the point stands: peptides come from factories and laboratories, not from nature in a jar.

The expensive 90%: purification and proof

Crude peptide off a synthesizer is a mixture. Turning it into something that can be put in a body is the industrial part of the industry:

• Purification. Preparative HPLC — industrial-scale liquid chromatography — separates the target molecule from its near-identical wrong-sequence relatives. This is slow, equipment-heavy, and where most of the cost lives.
• Verification. Analytical chemistry (LC-MS and related methods) confirms the sequence is the sequence, and measures how pure the batch actually is.
• Sterile fill and freeze-drying. Product destined for injection must be filled under sterile conditions and is usually freeze-dried (lyophilized) into the powder form buyers recognize — then tested for endotoxin, the bacterial contaminant that purity percentages do not measure and that has put people in hospital (an FDA Class I recall in October 2025 involved injectable product with endotoxin at 3,360 EU/mL).

A synthesizer makes crude peptide soup relatively cheaply. Purification, verification, sterile handling, and testing are the other 90% of the cost — and they are exactly the steps whose absence defines the gray market’s documented failure rates: roughly one in three samples failing basic quality checks in the largest independent dataset. The trade numbers, counted honestly · Contaminated products & forged lab reports

So — can you make your own?

Descriptively, the equipment exists and is sold openly to laboratories; nothing about the chemistry is secret. But three walls stand between a bench machine and a vial:

1. Economics. Between the synthesizer, the purification rig, the analytical instruments, sterile facilities, and freeze-drying, the honest setup costs orders of magnitude more than the finished product costs from industrial producers — whose concentration in China and India is itself a cost story (the imports page).
2. Verification. Without mass spectrometry and endotoxin testing, the maker cannot know what they made — identity, purity, or sterility. The gray market’s failure record is what production without this layer looks like at scale.
3. Law. Making peptides for your own research-lab use is one legal posture; making them for sale as products for human use is manufacturing an unapproved drug — the activity at the center of the FDA’s warning-letter and prosecution record, including a 70-month federal sentence in 2026 for a seller whose operation also forged its lab certificates.

The reason the market looks the way it does — industrial synthesis concentrated overseas, a verification economy of testing labs and certificates (some forged), and finished product flowing through channels with no quality gate — is that the molecule was never the hard part. The hard part is proving what’s in the vial. On that question this site has a standing rule: paperwork is a claim, testing is evidence, and the testing page shows what real verification looks like.

Read next

• The $328 Million Question: Peptide Imports from China
• How Peptides Are Taken: The Forms That Exist
• Contaminated Products & Forged Lab Reports

Educational information only — not medical or legal advice. Prepared November 9, 2026. See Our Legal Mandate.